Final MVVC and MVVC 2 meetings28 February 2015

The final MVVC and MVVC 2  meetings will take place at the Jenner Institute, Oxford, UK on 04-05 March 2015.  A final review of the projects' activities and the strategy for future steps will be discussed by the consortium partners.

New WHO release on neglected tropical diseases24 February 2015

WHO urges governments to increase investment to tackle neglected tropical diseases

Exciting career opportunity as Vaccine Management Assistant at EVI - new deadline11 February 2015

Deadline for applications 27 February 2015 17:00 CET.  Download PDF-version

EVI has an exciting career opportunity for junior and motivated individual to join the organisation in an eighteen month full time position as Vaccine Management Assistant (VMA) for a phase I vaccine clinical trial. 

WHO publishes "WHO Preferred Product Characteristics for Malaria Vaccines"30 January 2015

With reference to the updated Malaria Vaccine Technology Roadmap, WHO has published its preferred product characteristics for malaria vaccine.
WHO Preferred Product Characteristics for Malaria Vaccines (WHO/IVB/14.09)

Don't miss EVI's new malaria film30 January 2015

EVI has produced a short film illustrating the vital work being carried out in Africa in the battle against malaria in the institutions with whom EVI collaborates, and which is also exemplified by the MVVC project.

EURIPRED: second call for application for TransNational Access Services28 January 2015

European Research Infrastructures for Poverty Related Diseases (EURIPRED) has announced a seond call for application for TransNational Access Services. Deadline 27 February 2015

EVI New Year greetings26 January 2015

EVI sends New Year greetings to all colleagues, collaborators and friends around the world.  We hope that 2015 will bring us a decisive step closer to our goals

MVVC PhD student obtains his PhD degree12 January 2015

Muhammed Afolabi (MRC The Gambia) succefully concluded his PhD studies at the London School of Hygiene & Tropical Medicine on 8th January 2015. 

London School of Hygiene & Tropical Medicine is offering a short course07 January 2015

Epidemiological evaluation of vaccines: efficacy, safety and policy

The overall aim of this short course is to provide an understanding of the methods used in the evaluation of vaccines, from early human trials through to assessment of population impact and policy.

Almac Delivers Unique Long Peptide Vaccine for Clinical Trial05 January 2015

Almac Group, the contract development and manufacturing organization, today announced its key role in preparing and delivering one of the longest synthetically produced protein fragment to be used as a vaccine in a phase I clinical trial for malaria.